Atlas Trials

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Clinical trial NCT00070564 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00070564
Sponsor
SWOG Cancer Research Network
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2003-11-01
Primary completion
2015-01-01
Enrollment
3294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.